312) Patients undergoing UCB transplantation sh |
313) In asymptomatic patients undergoing ERNA who have normal s |
314) The prevalence of AR in patients undergoing HD seems higher than i |
315) A total of 54 patients undergoing HD were included in th |
316) tudies reported varying levels of pain in patients undergoing NPWT, with certain tre |
317) the other complications that are seen in patients undergoing UCB transplant are pos |
318) In summary, approximately half of patients undergoing a unilateral free flap |
319) in cannulation is frequently performed in patients undergoing electrophysiologic pro |
320) prevalence of aspirin resistance (AR) in patients undergoing hemodialysis (HD) and |
321) yseal fractures caused by minor trauma in patients undergoing long-term bisphosphona |
322) Patients had a mean age of 37·5 ± 14 |
323) nalysis indicated that intervention group patients had a hazard ratio of 0·19 (P = |
324) As many as 22% of the patients had been diagnosed with pulmonary |
325) Sixteen (80%) patients had closed surgical wounds, two ( |
326) At 30 days, 12% of the patients had died, and 9% remained hospita |
327) All but 2 patients had infected lesions on admission |
328) Two patients had local recurrence in the radia |
329) All treated patients had no postoperative surgical wou |
330) All patients had tentacle marks on their bodie |
331) The mortality risk of psychiatric patients was 1.6 times higher than that of |
332) Median follow-up for all patients was 13 months (range 3-51). |
333) The mean age of the patients was 33 years, 67% being female. |
334) The age of the patients was 47 and 66 years. |
335) The mean age of the patients was 63 years, with slight predomi |
336) ean parameter of color confusion index in patients was found to be statistically dif |
337) ld shear rate (THR) of young RBC from CVD patients was significantly higher than of |
338) ongation index (EI) of young RBC from CVD patients was significantly higher than of |
339) 55.3%) recognized that treatment for COPD patients was still required during stable |
340) Patients of age 0 to 64 years with HIV, ch |
341) Patients of group A in addition to the bas |
342) Patients of group A, in addition to the ba |
343) During the follow up, 4·25% of patients of Group B and 35·48% of patient |
344) for 3 months, whereas patients of group B received basic treatme |
|